Premature Infants With Respiratory Syncytial Virus (RSV): The Need for Both Maternal and Pediatric RSV Prevention Strategies

被引：1
|
作者：
Nicholson, Erin G. [1 ,2 ]
Piedra, Pedro A. [1 ,2 ]
机构：
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, MS280,One Baylor Plaza, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2020年 / 222卷 / 07期
关键词：
mortality; prematurity; respiratory syncytial virus; RSV; HOSPITALIZATION; INFECTIONS;
D O I：
10.1093/infdis/jiaa034
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1070 / 1072
页数：3
相关论文
共 50 条
  • [31] COMPARISON OF 2 RAPID METHODS FOR DETECTION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) (TESTPACK RSV AND ORTHO RSV ELISA) WITH DIRECT IMMUNOFLUORESCENCE AND VIRUS ISOLATION FOR THE DIAGNOSIS OF PEDIATRIC RSV INFECTION
    THOMAS, EE
    BOOK, LE
    JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (03) : 632 - 635
  • [32] A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
    B. Paes
    I. Mitchell
    A. Li
    K. L. Lanctôt
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 2703 - 2711
  • [33] A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
    Paes, B.
    Mitchell, I.
    Li, A.
    Lanctot, K. L.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (10) : 2703 - 2711
  • [34] Respiratory Syncytial Virus (RSV) Infection in Preterm Infants - Unmasking An Underdiagnosed Menace
    Yewale, Aabha Phalak
    Kalane, Shilpa
    Joshi, Rajan
    INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (8): : 859 - 859
  • [35] Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
    Beeler, Judy A.
    Eichelberger, Maryna C.
    MICROBIAL PATHOGENESIS, 2013, 55 : 9 - 15
  • [36] Eosinophil responses in wheezing infants with respect to infection with respiratory syncytial virus (RSV).
    deAlarcon, A
    Walsh, EE
    Gleich, GJ
    Rakes, GP
    LaRussa, JB
    Murphy, DD
    Carper, HT
    PlattsMills, TAE
    Heymann, PW
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1687 - 1687
  • [37] MODELED IMPACT OF NIRSEVIMAB AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) AMONG UK INFANTS EXPERIENCING THEIR FIRST RSV SEASON
    Beuvelet, M.
    Davidson, C.
    Hudson, R.
    Kieffer, A.
    VALUE IN HEALTH, 2022, 25 (01) : S125 - S125
  • [38] Palivizumab - the humanised monoclonal antibody for prevention of respiratory syncytial virus (RSV) infection
    Scholz, H
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2000, 204 (03): : 120 - 122
  • [39] Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications
    Acedo, L.
    Diez-Domingo, J.
    Morano, J. -A.
    Villanueva, R. -J.
    EPIDEMIOLOGY AND INFECTION, 2010, 138 (06): : 853 - 860
  • [40] DIAGNOSIS AND CONTROL OF NOSOCOMIAL RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTIONS IN A PEDIATRIC HOSPITAL
    INDERLIED, CB
    LEMMELIN, ME
    ODA, KJ
    COURVILLE, TM
    WRIGHT, HT
    PEDIATRIC RESEARCH, 1987, 21 (04) : A257 - A257
12345